Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
BrightGene tops Novo drug in diabetes ahead of Zepbound showdown
BrightGene beat semaglutide on a blood sugar endpoint, giving momentum as it barrels toward a readout from a head-to-head trial against tirzepatide.
Nick Paul Taylor
Jun 23, 2025 2:30pm
Exelixis beats Bayer drug in cancer trial, sending stock higher
Jun 23, 2025 7:30am
Novo's injectable amycretin yet to hit weight loss plateau
Jun 23, 2025 4:29am
Immuneering sees 94% survival at 6 months in pancreatic cancer
Jun 17, 2025 10:55am
Lilly's amylin data impress with 11% weight loss, tolerability
Jun 16, 2025 4:55am
NewAmsterdam links lipid drug to drop in Alzheimer's biomarker
Jun 9, 2025 8:25am
